• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Kidney cancer - Articles and news items

NICE approves former CDF kidney cancer drug for NHS use

Industry news / 12 January 2017 / Niamh Marriott, Digital Editor

Everolimus (Afinitor, Novartis) is now recommended to be available on the NHS as a treatment option for some patients with advanced renal cell carcinoma…

K is for Kidney

Blog / 28 November 2016 / Niamh Louise Marriott, Digital Editor

K is for Kidney – the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest research…

NICE recommends ‘breakthrough’ drug nivolumab for advanced renal cell cancer

Industry news / 21 October 2016 / Niamh Louise Marriott, Digital Content Producer

Nivolumab is an intravenous drug, a form of immunotherapy that works by harnessing the power of the patient’s own immune system to destroy the cancer cells…

Ipsen’s kidney cancer drug receives positive CHMP and ‘Promising Innovative Medicine’ status

Industry news / 25 July 2016 / Niamh Louise Marriott, Digital Content Producer

Ipsen announced that CHMP & EMA have provided a positive opinion for Cabometyx for the treatment of advanced renal cell carcinoma (RCC) in adults…